The largest database of trusted experimental protocols

13 protocols using htgf β1

1

Chondrogenic Differentiation of MSCs

Check if the same lab product or an alternative is used in the 5 most similar protocols
MSCs were kindly provided by the research group of Prof. Galderisi of the Department Experimental Medicine of University of Campania “Luigi Vanvitelli.” Chondrogenic differentiation was performed in GM10 based scaffolds. Briefly, the dried cross‐linked biomaterials were placed in a standard 24‐well culture plate, 5.0 × 104 MSCs aliquots were suspended in 10 μl of chondrogenic culture medium composed by: DMEM (Dulbecco's‐modified Eagle's medium, Gibco, Invitrogen) with 10% vol/vol of FBS (Fetal Bovine Serum, Gibco, MA, Invitrogen), 50 nM ascorbate‐2‐phosphate (Sigma‐Aldrich, MO, USA), 0.1 mM dexamethasone (Sigma‐Aldrich, Saint Louis, MO, USA), and 10 ng/ml of human transforming growth factor (hTGF)‐β1 (Preprotech, UK) and seeded in GM10, or GM10 + BC, or GM10 + CS based biomaterials. Once the culture medium containing the cells was completely absorbed by the hydrogels, other 500 μl of medium were added to each well to cover the scaffold (matrix). The MSCs containing biomaterials were maintained at 37°C in a humidified atmosphere with 5% vol/vol CO2 until 21 days, replacing the culture medium every 48 h.
+ Open protocol
+ Expand
2

Wnt/β-catenin Signaling Regulation in LR-MSCs

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human LR-MSCs were treated with or without hTGF-β1 (Cell Signaling Technology, Beverly, MA) at 10 ng/ml for indicated periods of time, and then harvested for analysis of the myofibroblast markers and the key components of Wnt/β-catenin signaling. A small-molecule inhibitor, ICG-001, which specifically disrupts β-catenin signaling in a CBP-dependent fashion has been reported in previous literature26 (link). Both human and mouse LR-MSCs were pretreated with ICG-001 (Selleckchem, Houston, TX) for 1 h, followed by incubation with 10 ng/ml hTGF-β1 or TGF-β1 (PeproTech, Rocky Hill, NJ) for 24 h. The cells were collected for Q-PCR, Western blot analysis, and immunofluorescence staining.
+ Open protocol
+ Expand
3

3D Chondrogenic Differentiation Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Chondrogenic differentiation was performed in 3D culture. Briefly, 1x105 cells were seeded as a pellet in 96 round bottom multi-wells and cultured in achondrogenic medium composed of DMEM, 1% FBS, 50 nM ascorbate-2-phosphate (Sigma-Aldrich, MO, USA), 0.1 mM dexamethasone (Sigma-Aldrich, Saint Louis, MO, USA), and 10 ng/mL human transforming growth factor (hTGF)-β1 (Preprotech, UK). The medium was replaced every 3 days. Differentiation was performed either in presence or in absence of the above indicated hyaluronan complexes.
After 21 days, Safranin O staining was performed to detect glycosaminoglycan formation on the cell surfaces, (Sigma-Aldrich, MO, USA) In short, cell pellets were fixed in cold (4°C) acetone:methanol solution for 60 min and then included in cryostat embedding medium (Bioptica, Italy) for cryosectioning. Pellet sections were incubated at room temperature in 1% Safranin O solution for 30 min followed by three rinses in 3% acetic acid for 2 min each. After rinsing in deionized water for 2 min, the surfaces were allowed to dry for imaging.
+ Open protocol
+ Expand
4

Chondrogenic Differentiation of MSCs

Check if the same lab product or an alternative is used in the 5 most similar protocols
MSCs were seeded as a pellet in 96 round-bottom multi-wells and cultured in a chondrogenic medium composed of DMEM, 1% FBS, 50 nM ascorbate-2-phosphate (Sigma-Aldrich, St. Louis, MO, USA), 0.1 mM dexamethasone (Sigma-Aldrich, MO, USA), and 10 ng/mL human transforming growth factor (hTGF)-β1 (PeproTech, London, UK). After 21 days, Safranin O staining was performed to detect glycosaminoglycan formation on the cell surfaces.
+ Open protocol
+ Expand
5

Differentiation of Murine T Helper 9 Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Naïve CD4 T cells were isolated from mouse spleens using CD4+CD62L+ T cell isolation kit provided by the supplier (Miltenyi Biotec). Cells were cultured in complete RPMI 1640 media on anti-CD3 (2 Units/ml 145–2C11; BioXCell) coated-plates and soluble anti-CD28 (2.5 μg/ml; BD Pharmingen) under TH9 polarizing conditions including: hTGF- β1 (2 ng/ml), IL-4 (20 ng/ml), hIL-2 (50 U/ml), anti-IL-10R (10 μg/ml) and anti-IFN-γ (10 μg/ml) (All cytokines were obtained from PeproTech and antibodies were obtained from BioXcell). On day 3, cells were expanded into fresh media containing the original concentrations of cytokines in the absence of co-stimulatory signals for an additional 2 days. On day 5, mature TH9 cells were harvested for further analysis.
+ Open protocol
+ Expand
6

TGF-β1 and BI6727 Induced Fibroblast Differentiation

Check if the same lab product or an alternative is used in the 5 most similar protocols
NIH/3T3 or primary cells were starved in DMEM without FBS for 24 h, and then cultured in DMEM with 5% FBS and 5 nM hTGF-β1 (Peprotech, 500-M66) or 10 nM BI6727 (Selleck, S2235) for three days. Immunofluorescence was performed as previously described [44 (link)].
+ Open protocol
+ Expand
7

Isolation and Differentiation of CD4+ T Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Total and CD4+ T cells were isolated from the spleens and LNs using the Mouse pan T Cell Enrichment Kit or the Mouse CD4+ T Cell Enrichment Kit, respectively (both STEMCELL Technologies; cat. nos 19852 and 19751). CD4+ T cells were stimulated with 1 μg ml−1 plate-bound anti-CD3 (clone 2C11) plus 1 μg ml−1 anti-CD28 antibodies (clone 37.51; both Bio X Cell). For differentiation of naive CD4+ T cells into TH1, TH17 and TH2 cells, T cells were polarized for 3 days with 10 ng ml−1 IL-12 (PeproTech) and 2 μg ml−1 anti-IL-4 (eBioscience) for TH1; 20 ng ml−1 IL-6 (PeproTech), 0.5 ng ml−1 hTGFβ1 (PeproTech), 2 μg ml−1 anti-IL-4 (clone 11B11) and 2 μg ml−1 anti-IFNγ (clone XMG1.2; both eBioscience) for TH17 and 100 ng ml−1 IL-4 (PeproTech), 5 μg ml−1 anti-IL-12 and 20 μg ml−1 anti-IFNγ (both eBioscience) for TH2 cells in IMDM or RPMI medium (both Cellgro). Both media contained 2 mM L-glutamine, 50 mM 2-ME, 100 U ml−1 penicillin/streptomycin and 10% FCS. For cytokine expression, cells were (re-)stimulated with 1 μM ionomycin plus 20 nM phorbol myristate acetate (both Calbiochem) for 6 h in the presence of brefeldin A (BioLegend) and analysed by flow cytometry as described below.
+ Open protocol
+ Expand
8

In Vivo T Cell Activation Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
All animal studies were performed according to National Institutes of Health (NIH) guidelines for the use and care of live animals and were approved by the Animal Care and Use Committees of the National Cancer Institute (NCI) under the protocol 20-073. C57BL/6 CD4-Cre transgenic, RAG−/− mice and Ifngr KO (JAX:003288) mice were obtained from the Jackson Laboratory and bred in our institute animal facility under specific pathogen–free conditions. Sptlc1foxl/flox mice were generated in our laboratory as previously described (34 (link)). Sptlc1foxl/floxCD4-Cre (KO) conditional KO mice were generated by crossing Sptlc1floxl/flox mice to CD4-Cre transgenic mice. Sptlc1foxl/flox or Sptlc1+/+CD4-Cre were used as control mice (WT). All mice used for experiments were aged 8 to 12 weeks, and both female and male mice were used for experiments. Primers for qPCR were obtained from IDT (Integrated DNA Technologies, USA). Cytokines mIL-4, mIL-12, hTGF-β1, IL-7, and IL-1β were purchased from PeproTech, USA; hIL-2 was obtained from R&D Systems; and IL-6 and IL-23 were purchased from BioLegend, USA. Antibodies for activation and cytokine neutralization were procured from Bio X Cell, USA. All chemicals were purchased from Sigma-Aldrich unless otherwise mentioned.
+ Open protocol
+ Expand
9

Differentiation of Pathogenic and Non-pathogenic Th17 Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
CD4+ T cells were isolated from the spleen and submandibular, axillar, inguinal, and mesenterial lymph nodes of mice by negative enrichment using a MagniSort mouse CD4+ T‐cell enrichment kit (eBioscience) and stimulated with 0.25 μg/ml plate‐bound anti‐CD3 (clone 2C11) and 1 μg/ml anti‐CD28 (clone 37.51; both Bio X Cell) antibodies in the presence of 2 μg/ml anti‐IL‐4 (clone 11B11) and 2 μg/ml anti‐IFN‐γ (clone XMG1.2; both eBioscience). For the differentiation into non‐pathogenic Th17 cells, CD4+ T cells were cultured in the presence of 20 ng/ml  IL‐6 (Peprotech) and 0.5 ng/ ml hTGFβ1 (PeproTech) for 2 or 3 days. For the differentiation into pathogenic Th17 cells, CD4+ T cells were cultured in the presence of 20 ng/ml IL‐6 (Peprotech), 20 ng/ml IL‐1β (Peprotech), and 20 ng/ml IL‐23 (eBioscience) for 2 or 3 days.
+ Open protocol
+ Expand
10

Osteoblast Signaling Pathway Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Primary osteoblasts stimulated with either hBMP2 (100 ng/ml) or hTGFβ1 (1 ng/ml; PeproTech) following starvation in serum-free medium for 6 h were lysed in lysis buffer (Cell Signaling Technology, Danvers, MA, USA) containing proteinase inhibitor (Roche). Vertebra samples (L5) were pulverized using a mortar and pestle, and suspended in the lysis buffer. Total protein amount was determined by BCA assay (Pierce, Waltham, MA, USA) and immunoblotting was performed with antibodies against pSmad1/5/8 (1:1000; #9511s, Cell Signaling Technology), Smad1/5/8 (1:1000; sc-6031, Santa Cruz Biotechnology, Dallas, TX, USA), pSmad3 (1:1000; #9520, Cell Signaling Technology), Smad3 (1:1000; #9523, Cell Signaling Technology), menin (1:10 000; A300-105A, Bethyl Laboratories, Montgomery, TX, USA), and β-actin (1:1000; sc-1616, Santa Cruz Biotechnology). Band intensity was analyzed using ImageJ software (NIH, Bethesda, MD, USA).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!